Equity Overview
Price & Market Data
Price: $2.04
Daily Change: -$0.12 / 5.88%
Daily Range: $2.02 - $2.23
Market Cap: $27,561,216
Daily Volume: 81,062
Performance Metrics
1 Week: -10.53%
1 Month: -17.07%
3 Months: -8.52%
6 Months: -64.46%
1 Year: -85.83%
YTD: -76.28%
Company Details
Employees: 46
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.